BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25431260)

  • 1. Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.
    Gautam PK; Acharya A
    Tumour Biol; 2015 Mar; 36(3):2023-32. PubMed ID: 25431260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed expression of homotypic multinucleation, extracellular domains of CD172α (SIRP-α) and CD47 (IAP) receptors in TAMs upregulated by Hsp70-peptide complex in Dalton's lymphoma.
    Gautam PK; Acharya A
    Scand J Immunol; 2014 Jul; 80(1):22-35. PubMed ID: 24684700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
    Calderwood SK; Theriault JR; Gong J
    Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28-mediated T cell response is upregulated by exogenous application of autologous Hsp70-peptide complex in a tumor-bearing host.
    Kumar S; Gautam PK; Tomar MS; Acharya A
    Immunol Res; 2016 Feb; 64(1):313-23. PubMed ID: 26639355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-immune functions of MHC class I glycoproteins in normal and malignant cells.
    Fishman D; Elhyany S; Segal S
    Folia Biol (Praha); 2004; 50(2):35-42. PubMed ID: 15222125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel Hsp70-based DNA vaccine as a multifunctional antigen delivery system.
    Yamaoka A; Guan X; Takemoto S; Nishikawa M; Takakura Y
    J Control Release; 2010 Mar; 142(3):411-5. PubMed ID: 19913062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
    Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
    Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced susceptibility to cytotoxic T lymphocytes without increase of MHC class I antigen expression after conditional overexpression of heat shock protein 70 in target cells.
    Dressel R; Lübbers M; Walter L; Herr W; Günther E
    Eur J Immunol; 1999 Dec; 29(12):3925-35. PubMed ID: 10602000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.
    Castelli C; Ciupitu AM; Rini F; Rivoltini L; Mazzocchi A; Kiessling R; Parmiani G
    Cancer Res; 2001 Jan; 61(1):222-7. PubMed ID: 11196165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic cytotoxic cells recognize surface HSP70 on culture-adapted EL-4 mouse lymphoma cells.
    Ponomarev ED; Tarasenko TN; Sapozhnikov AM
    Immunol Lett; 2000 Oct; 74(2):133-9. PubMed ID: 10996389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I antigens, immune surveillance, and tumor immune escape.
    Garcia-Lora A; Algarra I; Garrido F
    J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins.
    Breloer M; Fleischer B; von Bonin A
    J Immunol; 1999 Mar; 162(6):3141-7. PubMed ID: 10092763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity.
    Ueda G; Tamura Y; Hirai I; Kamiguchi K; Ichimiya S; Torigoe T; Hiratsuka H; Sunakawa H; Sato N
    Cancer Sci; 2004 Mar; 95(3):248-53. PubMed ID: 15016325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp70 induces Th1 polarization through tumor-associated macrophages in a T-cell lymphoma.
    Kumar S; Deepak P; Acharya A
    Neoplasma; 2007; 54(2):113-22. PubMed ID: 17319783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine.
    Casey DG; Lysaght J; James T; Bateman A; Melcher AA; Todryk SM
    Immunology; 2003 Sep; 110(1):105-11. PubMed ID: 12941147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of acute and permanent heat shock protein 70 overexpression in tumor cells on lysability by cytotoxic T lymphocytes.
    Dressel R; Grzeszik C; Kreiss M; Lindemann D; Herrmann T; Walter L; Günther E
    Cancer Res; 2003 Dec; 63(23):8212-20. PubMed ID: 14678977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.